GRANT | DATE | AMOUNT | PROGRAM |
---|---|---|---|
The University of Edinburgh
Building a cross-discipline scientific approach towards understanding Crohn's disease - Leveraging UK Helmsley Studies |
09.24.2024 | $47,977.00 | Crohn's Disease, Diagnostics |
University of Glasgow Court
Title: Unraveling the role of the gut microbiome in postoperative outcomes and disease recurrence in surgical adults with Crohn's disease treated with exclusive enteral nutrition. The MI-OCEAN study |
09.10.2024 | $3,187,027.00 | Crohn's Disease, Prevention |
The Regents of the University of Colorado, Denver
Epithelial mitochondrial dysfunction and extracellular vesicles in Crohn's disease fibrostenosis. |
08.13.2024 | $888,660.00 | Crohn's Disease, Disease Biology |
The Sheba Fund for Health Services and Research (R.A.)
The utility of hand-held ultrasound devices to detect bowel wall inflammatory activity in Crohn's disease |
07.24.2024 | $202,869.00 | Crohn's Disease, Disease Management |
Chancellor Masters & Scholars Of The University Of Oxford
Defining the signaling circuits and regulons mediating Crohn's fibrosis. |
07.24.2024 | $1,845,203.00 | Crohn's Disease, Disease Biology |
Crohn's & Colitis Foundation, Inc.
International Consortium on Medical Nutrition in IBD |
07.09.2024 | $310,748.00 | Crohn's Disease, Prevention |
Icahn School Of Medicine At Mount Sinai
Early life exposome biomarkers and Crohn's disease risk: The EARLY-CD project |
07.09.2024 | $1,281,867.00 | Crohn's Disease, Prevention |
The Bionics Institute of Australia
Patient-specific adaptive, electric therapy for Crohn's disease |
07.09.2024 | $3,189,010.00 | Crohn's Disease, Therapeutics |
The Royal Institution for the Advancement of Learning/McGill University
Data Governance Resource |
07.09.2024 | $558,424.00 | Crohn's Disease, Therapeutics |
St. Mark's Hospital Foundation
Support for the ongoing development of the TOpClass perianal Crohn's disease consortium, including support for meetings and website development; the development of a non-fistulising perianal Crohn's disease classification; and the creation of standard operating procedures for fistula research |
07.09.2024 | $254,998.00 | Crohn's Disease, Diagnostics |
Human Cell Atlas, Incorporated
2024 Human Cell Atlas General Meeting |
06.05.2024 | $50,000.00 | Crohn's Disease, Therapeutics |
The Scripps Research Institute
Crohn's Fistulizing Program – Investigator Initiated Clinical Trials |
06.05.2024 | $3,778,831.00 | Crohn's Disease, Therapeutics |
Crohn's Colitis Cure
Enhancing Inflammatory Bowel Disease Care: Consumer-Centric Portal for Better Communication & Reduced Navigation Stress |
06.05.2024 | $1,863,018.00 | Crohn's Disease, Disease Management |
Icahn School Of Medicine At Mount Sinai
The Women with Inflammatory Bowel Disease and Motherhood (WIsDoM) Registry: A Prospective Study of Female Fertility in IBD |
06.05.2024 | $1,752,087.00 | Crohn's Disease, Disease Management |
ImproveCareNow, Inc.
Implementing the COMBINE Trial Results in the ImproveCareNow (ICN) Learning Health Network |
05.15.2024 | $2,575,455.00 | Crohn's Disease, Disease Management |
The Broad Institute, Inc.
Novel therapeutic approaches for Crohn's disease |
05.01.2024 | $10,473,815.00 | Crohn's Disease, Disease Biology |
Icahn School Of Medicine At Mount Sinai
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease [CATHARSIS Trial] |
05.01.2024 | $1,575,823.00 | Crohn's Disease, Disease Management |
Society For Mucosal Immunology Inc
21st International Congress of Mucosal Immunology (ICMI 2024) |
04.02.2024 | $15,000.00 | Crohn's Disease, Disease Biology |
Katholieke Universiteit te Leuven
EMBODY: Effects of a Mindfulness Based interventiOn on ibD disabilitY |
03.06.2024 | $626,850.00 | Crohn's Disease, Disease Management |
Katholieke Universiteit te Leuven
Fat as a villain in Crohn's disease. |
02.20.2024 | $2,801,504.00 | Crohn's Disease, Disease Biology |
Prev
12...14
Next
1 - 20 of 275 results
|